Evidence map›Paper›PMID 41245263›Full record

ArticleKidney medicine2025

Corrigendum to IgA Nephropathy: An Overview of the Clinical Trials (

Zohreh Gholizadeh Ghozloujeh, Haresh Selvaskandan, Nasim Wiegley, Edgar Lerma, Jorge Gaytan, Alejandro Garcia-Rivera, Amir Abdipour, Sayna Norouzi

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Zohreh Gholizadeh GhozloujehDepartment of Medicine, Division of Nephrology, Loma Linda University, Loma Linda, CA.
Haresh SelvaskandanJohn Walls Renal Unit, University Hospitals Leicester NHS Trust, Leicester, UK.
Nasim WiegleyDepartment of Medicine, Division of Nephrology, University of California Davis School of Medicine, Division of Nephrology, Sacramento, CA.
Edgar LermaDepartment of Medicine, Section of Nephrology, Advocate Christ Medical Center, University of Illinois at Chicago, Oak Lawn, IL.
Jorge GaytanDivision of Medicine, Department of Internal Medicine and Nephrology, High Specialty Medical Unit No. 71, Mexican Social Security Institute (IMSS), Torreon, Mexico.
Alejandro Garcia-RiveraDepartment of Nephrology, Hospital General Regional 46, Instituto Mexicano del Seguro Social, Guadalajara, Mexico.
Amir AbdipourDepartment of Medicine, Division of Nephrology, Loma Linda University, Loma Linda, CA.
Sayna NorouziDepartment of Medicine, Division of Nephrology, Loma Linda University, Loma Linda, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.xkme.2025.101078.].

Identifiers

PMID41245263
PMCPMC12615271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.